NCT07241091Completed
SurgiPerito Trial: High-Purity Type-I Collagen for Peritoneal Reconstruction After Cytoreductive Surgery
A Randomized Controlled Trial of High-Purity Type-I Collagen-Based Biomaterial (Surgicoll-Mesh®) as a Peritoneal Substitute to Prevent Post-Peritonectomy Complications in Patients Undergoing Cytoreductive Surgery
Source: ClinicalTrials.gov · Last updated 30 Mar 2026
Brief summary (registry, in English)
This dual-centre, randomized controlled trial evaluates the safety and efficacy of high-purity Type-I collagen-based biomaterial, as a peritoneal substitute following peritonectomy in patients undergoing cytoreductive surgery (CRS) for peritoneal surface malignancy. The study tests whether Surgicoll-Mesh can reduce major postoperative intra-abdominal complications compared with standard management.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 60 (actual)
- First submitted
- 17 Nov 2025
- Start date
- 20 Oct 2025
- Primary completion date
- 13 Feb 2026
- Lead sponsor
- Adichunchanagiri Institute of Medical Sciences, B G Nagara
- Diseases
- Ovarian cancer
- NCT number
- NCT07241091
What you commit to
- Study type: Interventional
- Participants enrolled: 60
- From 20 Oct 2025 to the primary completion date, 13 Feb 2026
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study design.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Immunosuppression or chronic steroid use
Other illness
- Collagen allergy or active infection
- Uncontrolled sepsis, bowel perforation, or extensive small bowel resection
Other
- Pregnancy/lactation
Who the study is looking for
- Age ≥18 years
- Diagnosed peritoneal surface malignancy (colorectal, ovarian, appendiceal, mesothelioma, pseudomyxoma)
- Undergoing cytoreductive surgery ± HIPEC requiring peritonectomy
- ECOG 0-2, adequate organ function, informed consent
Age in the registry: 18 years to 75 years · Sex: All · Does not accept healthy volunteers
Sites (2)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Adichunchanagiri Institute of Medical Sciences Coordinator of this site? Confirm its status | Mandya | India | Unknown status |
| JSS Medical College Hospital Coordinator of this site? Confirm its status | Mysore | India | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.